Healthcare | Crain's Indianapolis

Business news covering insurance, research, drug companies and treatments.

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Brenda Stallings

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Elizabeth Dunlap

Background:  

Fintech startup expands to meet growing need for medical loans

LendingPoint CEO Tom Burnside is one of the company's four co-founders. | Photo submitted

July 2, 2017 - 12:55pm

The nose knows: Specialty firm evaluates all things stinky

From left Chuck, Donna and Mike McGinley take a break in a gazebo overlooking Stillwater’s historic lift bridge on the St. Croix River. | Photo courtesy of Cami Enke, Hazel Brown and Blue Photography.

May 25, 2017 - 4:35pm

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Emily Culp

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

David L. Johnson

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Todd Hopkins

Background:  

Ed-tech firm makes splash on campuses with self-assessment courseware

Perceivant President Christopher Johnson and marketing/content manager Nicole O’Neal at work at the company’s Fort Benjamin Harrison offices in Indiana. | Photo by Chris O’Malley/Crain’s Indianapolis

February 8, 2017 - 3:39pm

Connecticut ‘politely sweating out’ Anthem, Cigna merger drama

Cigna President and CEO David Cordani speaks at the ceremony marking the relocation of his company's headquarters to Connecticut. Gov. Dannel Malloy and Lt. Gov. Nancy Wyman are behind Cordani. | Photo courtesy of the Connecticut Governor's Office

February 4, 2017 - 11:27pm

A decade later, Future Fund investment in CoLucid pays off

Eli Lilly and Co.’s $960 million purchase of CoLucid validated the creation of the Indiana Future Fund, which invested $16.5 million in CoLucid a decade earlier, said BioCrossroads CEO David Johnson. “Nothing like that had ever been done before” in the region. | Photo courtesy of BioCrossroads.

February 3, 2017 - 11:51am

Pages